In addition, the downstream effector of inflammasome, interleukin-1β was elevated in aortic tissue of AD, while interleukin-1β blocking could delay the progression through inhibiting the expression of MMP-2 and MMP-9 and the breakage of elastin fibers (41, 42). The gene discussed is MMP9; the disease is Alzheimer disease.